Insider Transactions Reported by 7 Insiders of Tg Therapeutics, Inc.

Symbol
TGTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
New York, NY

Insiders trading volume in the past year

Tg Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael S. Weiss CEO, Director $331M Nov 5, 2025
Sean A. Power Cfo $20.2M -$629K -3.02% Jan 29, 2025
Kenneth Hoberman Director $9.33M Jun 12, 2025
Laurence N. Charney Director $7.44M Jun 12, 2025
Yann Echelard Director $7.29M -$532K -6.8% Nov 24, 2025
Daniel Hume Director $6.43M Jun 12, 2025
Sagar Lonial Director $3.83M -$672K -14.9% Sep 11, 2025

Recent Insider Transactions by Companies or Individuals for Tg Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.